318 related articles for article (PubMed ID: 17502453)
1. Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells.
Ong CJ; Ming-Lum A; Nodwell M; Ghanipour A; Yang L; Williams DE; Kim J; Demirjian L; Qasimi P; Ruschmann J; Cao LP; Ma K; Chung SW; Duronio V; Andersen RJ; Krystal G; Mui AL
Blood; 2007 Sep; 110(6):1942-9. PubMed ID: 17502453
[TBL] [Abstract][Full Text] [Related]
2. Src homology 2 domain-containing inositol-5-phosphatase 1 (SHIP1) negatively regulates TLR4-mediated LPS response primarily through a phosphatase activity- and PI-3K-independent mechanism.
An H; Xu H; Zhang M; Zhou J; Feng T; Qian C; Qi R; Cao X
Blood; 2005 Jun; 105(12):4685-92. PubMed ID: 15701712
[TBL] [Abstract][Full Text] [Related]
3. Characterization of AQX-1125, a small-molecule SHIP1 activator: Part 1. Effects on inflammatory cell activation and chemotaxis in vitro and pharmacokinetic characterization in vivo.
Stenton GR; Mackenzie LF; Tam P; Cross JL; Harwig C; Raymond J; Toews J; Wu J; Ogden N; MacRury T; Szabo C
Br J Pharmacol; 2013 Mar; 168(6):1506-18. PubMed ID: 23121445
[TBL] [Abstract][Full Text] [Related]
4. A mouse Fcgamma-Fcepsilon protein that inhibits mast cells through activation of FcgammaRIIB, SH2 domain-containing inositol phosphatase 1, and SH2 domain-containing protein tyrosine phosphatases.
Mertsching E; Bafetti L; Hess H; Perper S; Giza K; Allen LC; Negrou E; Hathaway K; Hopp J; Chung J; Perret D; Shields M; Saxon A; Kehry MR
J Allergy Clin Immunol; 2008 Feb; 121(2):441-447.e5. PubMed ID: 17949802
[TBL] [Abstract][Full Text] [Related]
5. The role of SHIP1 in macrophage programming and activation.
Rauh MJ; Sly LM; Kalesnikoff J; Hughes MR; Cao LP; Lam V; Krystal G
Biochem Soc Trans; 2004 Nov; 32(Pt 5):785-8. PubMed ID: 15494015
[TBL] [Abstract][Full Text] [Related]
6. Regulation of the Src homology 2 domain-containing inositol 5'-phosphatase (SHIP1) by the cyclic AMP-dependent protein kinase.
Zhang J; Walk SF; Ravichandran KS; Garrison JC
J Biol Chem; 2009 Jul; 284(30):20070-8. PubMed ID: 19494109
[TBL] [Abstract][Full Text] [Related]
7. Macrophages from 11beta-hydroxysteroid dehydrogenase type 1-deficient mice exhibit an increased sensitivity to lipopolysaccharide stimulation due to TGF-beta-mediated up-regulation of SHIP1 expression.
Zhang TY; Daynes RA
J Immunol; 2007 Nov; 179(9):6325-35. PubMed ID: 17947710
[TBL] [Abstract][Full Text] [Related]
8. Leukemia-associated mutations in SHIP1 inhibit its enzymatic activity, interaction with the GM-CSF receptor and Grb2, and its ability to inactivate PI3K/AKT signaling.
Brauer H; Strauss J; Wegner W; Müller-Tidow C; Horstmann M; Jücker M
Cell Signal; 2012 Nov; 24(11):2095-101. PubMed ID: 22820502
[TBL] [Abstract][Full Text] [Related]
9. TREM2- and DAP12-dependent activation of PI3K requires DAP10 and is inhibited by SHIP1.
Peng Q; Malhotra S; Torchia JA; Kerr WG; Coggeshall KM; Humphrey MB
Sci Signal; 2010 May; 3(122):ra38. PubMed ID: 20484116
[TBL] [Abstract][Full Text] [Related]
10. SHIP1 and its role for innate immune regulation-Novel targets for immunotherapy.
Yeoh WJ; Krebs P
Eur J Immunol; 2023 Dec; 53(12):e2350446. PubMed ID: 37742135
[TBL] [Abstract][Full Text] [Related]
11. Insulin and insulin-like growth factor-1 promote mast cell survival via activation of the phosphatidylinositol-3-kinase pathway.
Lessmann E; Grochowy G; Weingarten L; Giesemann T; Aktories K; Leitges M; Krystal G; Huber M
Exp Hematol; 2006 Nov; 34(11):1532-41. PubMed ID: 17046573
[TBL] [Abstract][Full Text] [Related]
12. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase.
Bago R; Malik N; Munson MJ; Prescott AR; Davies P; Sommer E; Shpiro N; Ward R; Cross D; Ganley IG; Alessi DR
Biochem J; 2014 Nov; 463(3):413-27. PubMed ID: 25177796
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 inhibits lipopolysaccharide-induced tumor necrosis factor-α translation through a SHIP1-dependent pathway.
Chan CS; Ming-Lum A; Golds GB; Lee SJ; Anderson RJ; Mui AL
J Biol Chem; 2012 Nov; 287(45):38020-7. PubMed ID: 22955274
[TBL] [Abstract][Full Text] [Related]
14. Control of cell polarity and motility by the PtdIns(3,4,5)P3 phosphatase SHIP1.
Nishio M; Watanabe K; Sasaki J; Taya C; Takasuga S; Iizuka R; Balla T; Yamazaki M; Watanabe H; Itoh R; Kuroda S; Horie Y; Förster I; Mak TW; Yonekawa H; Penninger JM; Kanaho Y; Suzuki A; Sasaki T
Nat Cell Biol; 2007 Jan; 9(1):36-44. PubMed ID: 17173042
[TBL] [Abstract][Full Text] [Related]
15. The role of SHIP1 in T-lymphocyte life and death.
Gloire G; Erneux C; Piette J
Biochem Soc Trans; 2007 Apr; 35(Pt 2):277-80. PubMed ID: 17371259
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms controlling membrane recruitment and activation of the autoinhibited SHIP1 inositol 5-phosphatase.
Waddell GL; Drew EE; Rupp HP; Hansen SD
J Biol Chem; 2023 Aug; 299(8):105022. PubMed ID: 37423304
[TBL] [Abstract][Full Text] [Related]
17. Reversible Ser/Thr SHIP phosphorylation: a new paradigm in phosphoinositide signalling?: Targeting of SHIP1/2 phosphatases may be controlled by phosphorylation on Ser and Thr residues.
Edimo WE; Janssens V; Waelkens E; Erneux C
Bioessays; 2012 Aug; 34(8):634-42. PubMed ID: 22641604
[TBL] [Abstract][Full Text] [Related]
18. SHIP1 is a repressor of mast cell hyperplasia, cytokine production, and allergic inflammation in vivo.
Haddon DJ; Antignano F; Hughes MR; Blanchet MR; Zbytnuik L; Krystal G; McNagny KM
J Immunol; 2009 Jul; 183(1):228-36. PubMed ID: 19542434
[TBL] [Abstract][Full Text] [Related]
19. The Src homology 2-containing inositol 5-phosphatase 1 (SHIP1) is involved in CD32a signaling in human neutrophils.
Vaillancourt M; Levasseur S; Tremblay ML; Marois L; Rollet-Labelle E; Naccache PH
Cell Signal; 2006 Nov; 18(11):2022-32. PubMed ID: 16682172
[TBL] [Abstract][Full Text] [Related]
20. Role of SHIP1 in bone biology.
Iyer S; Margulies BS; Kerr WG
Ann N Y Acad Sci; 2013 Mar; 1280():11-4. PubMed ID: 23551095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
